Hutchison MediPharma Limited is a leading biotechnology company in China. It was founded in Shanghai’s Zhangjiang High Tech Park in September 2002 with financial support from the Hutchison Whampoa Group. Since then, the company has built one of the largest and most experienced new drug R&D teams in China with over 200 employees, of whom more than 30% are MD/PhDs and more than 50% have masters degrees. It is led by a first class senior management team, all of whom have many years of experience succeeding at large US pharmaceutical and biotech companies.

Hutchison MediPharma's Competitive Advantages Include:

► A China-based, world-class team with a proven track record in new drug research & 
     development in cancer and autoimmune diseases

► Substantial experience pursuing innovative drug discovery and clinical development in China at
     global standard and quality levels

► A vertically integrated platform that facilitates closely interdependent problem solving to harness
     the collective expertise of the various disciplines

► A demonstrated track record of high operational efficiency and delivery